OptimizeRx OPRX D&A
D&A at other companies
Other financials
Where this comes from
Reported directly by OptimizeRx in its filing.
Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.
The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about OptimizeRx's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OptimizeRx's D&A?
- OptimizeRx (OPRX) reported D&A of $1.06M in Q1 2026.
- How has OptimizeRx's D&A changed year-over-year?
- OptimizeRx's D&A decreased by 2.7% year-over-year, from $1.09M to $1.06M.
- What is the long-term trend for OptimizeRx's D&A?
- Over 3 years (2022 to 2025), OptimizeRx's D&A has grown at a 28.9% compound annual growth rate (CAGR), from $2.02M to $4.33M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.